These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7176839)

  • 1. Prednisone treatment of chronic liver disease. I. Chronic aggressive hepatitis as a therapeutic marker.
    Schlichting P; Fauerholdt L; Christensen E; Poulsen H; Juhl E; Tygstrup N
    Liver; 1982 Jun; 2(2):104-12. PubMed ID: 7176839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisone and chronic liver disease. II. Clinical versus morphological criteria for selection of patients for prednisone treatment.
    Schlichting P; Christensen E; Fauerholdt L; Poulsen H; Juhl E; Tygstrup N
    Liver; 1982 Jun; 2(2):113-8. PubMed ID: 7176840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Azathioprine versus prednisone in chronic active hepatitis and non-alcoholic cirrhosis. Effect on survival and activity.
    Scand J Gastroenterol; 1982 Sep; 17(6):817-24. PubMed ID: 6760378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunosuppressive treatment of patients with chronic active HBsAg positive hepatitis].
    Tanno H; Fay O; Roldán L; Vorovioff J
    Acta Gastroenterol Latinoam; 1982; 12(4):323-32. PubMed ID: 7185230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver biopsy in chronic aggressive hepatitis. Diagnostic reproducibility in relation to size of specimen.
    Schlichting P; Hølund B; Poulsen H
    Scand J Gastroenterol; 1983 Jan; 18(1):27-32. PubMed ID: 6675176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical relevance of restrictive morphological criteria for the diagnosis of cirrhosis in liver biopsies.
    Schlichting P; Fauerholdt L; Christensen E; Poulsen H; Juhl E; Tygstrup N
    Liver; 1981 Mar; 1(1):56-61. PubMed ID: 7348755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A therapeutic index that predicts the individual effects of prednisone in patients with cirrhosis.
    Christensen E; Schlichting P; Andersen PK; Fauerholdt L; Juhl E; Poulsen H; Tygstrup N
    Gastroenterology; 1985 Jan; 88(1 Pt 1):156-65. PubMed ID: 3880556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectivity of immunosuppressive therapy on chronic aggressive (active) hepatitis and on chronic nonsuppurative destructive cholangitis (PBC). Morphometric investigations on the portal tracts of the liver.
    Volmer J
    Liver; 1982 Jun; 2(2):82-94. PubMed ID: 7176844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of bridging necrosis in chronic active hepatitis.
    Okuno T; Okanoue T; Takino T; Mori K
    Gastroenterol Jpn; 1983 Dec; 18(6):577-84. PubMed ID: 6671513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azathioprine versus prednisone in non-alcoholic chronic liver disease (CLD). Relation to a serological classification.
    Tage-Jensen U; Schlichting P; Aldershvile J; Andersen P; Dietrichson O; Hardt F; Mathiesen LR; Nielsen JO
    Liver; 1982 Jun; 2(2):95-103. PubMed ID: 7176845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term prognosis of chronic B and C viral hepatitis].
    Ohlen J; Liegl JM; Selmair H
    Leber Magen Darm; 1995 Sep; 25(5):205-10. PubMed ID: 7500807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of pre- and post-treatmental hepatohistology with heavy dosage of Paeonia rubra on chronic active hepatitis caused liver fibrosis].
    Yang DG
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1994 Apr; 14(4):207-9, 195. PubMed ID: 7950194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in the morphological spectrum and clinical outcome of chronic liver disease in hepatitis B-positive and B-negative renal transplant recipients.
    Rao KV; Kasiske BL; Anderson WR
    Transplantation; 1991 Feb; 51(2):391-6. PubMed ID: 1994533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of liver histology in chronic active hepatitis C and chronic active hepatitis B.
    Shah HA; Kayani N; Sheikh H; Jafri SW; Hamid S; Khan AH
    Indian J Gastroenterol; 1995 Jul; 14(3):91-4. PubMed ID: 7544766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcoholic hepatitis superimposed on cirrhosis. Clinical significance and effect of long-term prednisone treatment.
    Schlichting P; Juhl E; Poulsen H; Winkel P
    Scand J Gastroenterol; 1976; 11(3):305-12. PubMed ID: 775615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis.
    Schvarcz R; Glaumann H; Weiland O
    J Hepatol; 1993 Apr; 18(1):15-23. PubMed ID: 7688011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prednisone on the survival of patients with cirrhosis of the liver. A report from the Copenhagen Study Group for Liver Diseases.
    Lancet; 1969 Jan; 1(7586):119-21. PubMed ID: 4178242
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of short-term, high-dose prednisone treatment of patients with HBsAg-positive chronic active hepatitis.
    Nair PV; Tong MJ; Stevenson D; Roskamp D; Boone C
    Liver; 1985 Feb; 5(1):8-12. PubMed ID: 3884951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of therapeutic effectiveness of prednisolone in patients with chronic active hepatitis based on the morphometry of liver biopsy specimens].
    Mansurov KhKh; Mirodzhov GK; Mishanina ZG; Pavlov VL
    Ter Arkh; 1985; 57(2):77-80. PubMed ID: 3890253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex, ascites and alcoholism in survival of patients with cirrhosis. Effect of prednisone.
    Copenhagen Study Group for Liver Diseases
    N Engl J Med; 1974 Aug; 291(6):271-3. PubMed ID: 4600899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.